BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11775420)

  • 1. [Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomized trial].
    Costalunga A; Gavazzi A
    Ital Heart J Suppl; 2001 Nov; 2(11):1246-7. PubMed ID: 11775420
    [No Abstract]   [Full Text] [Related]  

  • 2. New evidence from the CAPRICORN Trial: the role of carvedilol in high-risk, post-myocardial infarction patients.
    Sackner-Bernstein JD
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S25-9. PubMed ID: 14564231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Landmark study: the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction Study (CAPRICORN).
    Colucci WS
    Am J Cardiol; 2004 May; 93(9A):13B-6B. PubMed ID: 15144931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial.
    McMurray J; Køber L; Robertson M; Dargie H; Colucci W; Lopez-Sendon J; Remme W; Sharpe DN; Ford I
    J Am Coll Cardiol; 2005 Feb; 45(4):525-30. PubMed ID: 15708698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and methodology of the CAPRICORN trial - a randomised double blind placebo controlled study of the impact of carvedilol on morbidity and mortality in patients with left ventricular dysfunction after myocardial infarction.
    Dargie HJ
    Eur J Heart Fail; 2000 Sep; 2(3):325-32. PubMed ID: 10938495
    [No Abstract]   [Full Text] [Related]  

  • 6. Carvedilol following AMI.
    Herner SJ; Seaton TL
    J Fam Pract; 1997 Oct; 45(4):288-9. PubMed ID: 9379146
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials?
    Otterstad JE; Ford I
    Eur J Heart Fail; 2002 Aug; 4(4):501-6. PubMed ID: 12167391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy.
    Doughty RN; Whalley GA; Walsh HA; Gamble GD; López-Sendón J; Sharpe N;
    Circulation; 2004 Jan; 109(2):201-6. PubMed ID: 14707020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial.
    Dargie HJ
    Lancet; 2001 May; 357(9266):1385-90. PubMed ID: 11356434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carvedilol saves lives--new data from landmark trials prove survival benefits in heart failure and post myocardial infarction.
    Cardiovasc J S Afr; 2001; 12(2):122-3. PubMed ID: 11474697
    [No Abstract]   [Full Text] [Related]  

  • 11. CAPRICORN: a story of alpha allocation and beta-blockers in left ventricular dysfunction post-MI.
    Coats AJ
    Int J Cardiol; 2001 Apr; 78(2):109-13. PubMed ID: 11334653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of beta blockers, particularly carvedilol, on reducing the risk of events after acute myocardial infarction.
    Kopecky SL
    Am J Cardiol; 2006 Oct; 98(8):1115-9. PubMed ID: 17027583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Beta blockers in post-infarction state].
    Schultheiss HP; Tschöpe C
    Herz; 2002 Aug; 27 Suppl 1():26-9. PubMed ID: 12229255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does carvedilol have antiarrhythmic properties?
    Naccarelli GV
    Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):338-9. PubMed ID: 16265556
    [No Abstract]   [Full Text] [Related]  

  • 15. Now there are four: Carvedilol takes its place in therapeutical line-up for heart failure.
    Phillips L
    Hosp Technol Ser; 1997 Mar; 16(3):6-7. PubMed ID: 10166705
    [No Abstract]   [Full Text] [Related]  

  • 16. Carvedilol: use in chronic heart failure.
    Doughty RN; White HD
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Carvedilol in ischemic heart failure. Hibernating myocardium resuscitated].
    MMW Fortschr Med; 2003 Feb; 145(8):57. PubMed ID: 12661451
    [No Abstract]   [Full Text] [Related]  

  • 18. Randomized active-controlled study comparing effects of treatment with carvedilol versus metoprolol in patients with left ventricular dysfunction after acute myocardial infarction.
    Mrdovic IB; Savic LZ; Perunicic JP; Asanin MR; Lasica RM; Jelena MM; Matic MD; Vasiljevic ZM; Ostojic MC
    Am Heart J; 2007 Jul; 154(1):116-22. PubMed ID: 17584563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carvedilol prevents remodeling in patients with left ventricular dysfunction after acute myocardial infarction.
    Senior R; Basu S; Kinsey C; Schaeffer S; Lahiri A
    Am Heart J; 1999 Apr; 137(4 Pt 1):646-52. PubMed ID: 10097224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of carvedilol on parameters of myocardial perfusion in patients with left ventricular remodeling after myocardial infarction].
    Kardiologiia; 2009; 49(2):66. PubMed ID: 19254220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.